To determine whether YB-1 is required for the de novo genesis of tumours derived directly from oncogenically perturbed normal human mammary cells, we used the same YB-1 knockdown strategy applied above to the MDA-MB-231 cells. This evidence concerns the gene YBX1 and neoplasm.